Ready For Soft Launch Of Single Window System For Clearances And Approvals: DPIIT Official

New Delhi : The Central government is ready for a soft launch of its Single Window System for clearances and approvals for the industry in the country and this would help industries in future, said Sumita Dawra, additional secretary, Department for Promotion of Industry and Internal Trade (DPIIT).

Addressing the medical technology industry representatives in a plenary session on demand generation, triggering the growth of med tech industry, organised by Confederation of Indian Industry (CII) in its 13th Global MedTech Summit, she said that the DPIIT has conducted demonstrations on the system, which is a budgetary announcement last year, to the industry associations.

“We are ready for a soft launch with many of the critical ministries and many of the States on the board. There is very good progress under the National Single Window System and that integrates the clearance portals of various ministries across Government of India and also the clearances which the State governments at one place without disturbing the existing systems,” she told the industry.

While Covid-19 has caused a lot of disruptions in the economy and otherwise, it also presented a great opportunity for the country to adapt and grow in certain sectors. For instance in terms of oxygen supply, the government rose to the situation and made it possible to supply close to 10,000 metric tonnes of oxygen on a daily basis.

It is very timely to not just mapping these opportunities, but also to act proactively. DPIIT is to play the role of facilitator to create a more business friendly environment for investments both domestic and foreign.

The government has launched the production linked incentive scheme in 13 sectors, including for Medical Devices. This is a very important opportunity for taking manufacturing to global scale and making India as a global manufacturing hub.

The establishment of an empowered group of secretaries, which is headed by the Cabinet Secretary, for taking decisions on cross cutting policy issues and it is supported by the project development cells, is another move to support the industry. The Group comprises officials across about 13 ministries and departments in the Government of India to handhold the investors and facilitate them – both domestic and global.

Wherever there is any obstruction which the investor sees with respect to the investments whether with the State governments or with the other departments of the GoI, it is the Project Development Cell in the domain sector ministry which handholds the investors and fast track them. These activities are also reviewed very closely, she added.

There are ongoing efforts to improve ease of doing business and reduce the compliance burden, she averred.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states